These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20456038)

  • 1. How to overcome multidrug resistance in chemotherapy for advanced hepatocellular carcinoma.
    Ryu SH; Chung YH
    Liver Int; 2010 Apr; 30(4):496-8. PubMed ID: 20456038
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma.
    Li G; Dong S; Qu J; Sun Z; Huang Z; Ye L; Liang H; Ai X; Zhang W; Chen X
    Liver Int; 2010 Apr; 30(4):585-92. PubMed ID: 19780956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases.
    Yang TS; Chang HK; Chen JS; Lin YC; Liau CT; Chang WC
    J Gastroenterol; 2004; 39(4):362-9. PubMed ID: 15168248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the combined treatment with thalidomide, megestrol and interleukine-2 in cirrhotic patients with advanced hepatocellular carcinoma. A pilot study.
    Cappa FM; Cantarini MC; Magini G; Zambruni A; Bendini C; Santi V; Bernardi M; Trevisani F
    Dig Liver Dis; 2005 Apr; 37(4):254-9. PubMed ID: 15788209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
    Wen J; Shen WL; Yang SH
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MDR (multidrug resistance) in hepatocarcinoma clinical-therapeutic implications].
    Petraccia L; Onori P; Sferra R; Lucchetta MC; Liberati G; Grassi M; Gaudio E
    Clin Ter; 2003; 154(5):325-35. PubMed ID: 14994922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma.
    Kuroda M; Kobayashi Y; Urawa N; Yamamoto M; Mifuji R; Araki J; Tanaka H; Horiike S; Itani T; Furjita N; Konishi M; Iwasa M; Kaito M; Adachi Y
    Hepatogastroenterology; 2007 Mar; 54(74):518-21. PubMed ID: 17523311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term outcome of advanced hepatocellular carcinoma that received transarterial hepatic chemotherapy].
    Masutani S; Shimizu J; Tatsuta M; Masuda F; Imamura H; Ishida H; Furukawa H; Tomotsu K; Yura M; Obana T; Kitamura S; Saeki N; Inoue Y; Takamura M; Ohnishi H
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1579-82. PubMed ID: 14619468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postoperative adjuvant intraarterial chemotherapy of combined cisplatin and 5-FU for advanced hepatocellular carcinoma].
    Kamiyama T; Nakagawa T; Nakanishi K; Kurauchi N; Kamachi H; Matsushita M; Todo S
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1618-20. PubMed ID: 14619478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with low-dose oral chemotherapy in a patient with metastatic hepatocellular carcinoma.
    Di Meglio G; Fazio N; Nolè F; Della Vigna P; Lorizzo K; Goldhirsch A; Farris A
    Acta Oncol; 2007; 46(8):1205-6. PubMed ID: 17978934
    [No Abstract]   [Full Text] [Related]  

  • 11. [Usefulness of continuous arterial infusion chemotherapy for post operative multiple recurrence and residual hepatocellular carcinoma].
    Yanagi I; Koga A; Okuda K; Nishio T; Shibata J; Aso K; Matuo H; Nagashima J; So H; Nakayama T
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1419-21. PubMed ID: 8854768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
    Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
    Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.
    Ando E; Tanaka M; Yamashita F; Kuromatsu R; Yutani S; Fukumori K; Sumie S; Yano Y; Okuda K; Sata M
    Cancer; 2002 Aug; 95(3):588-95. PubMed ID: 12209752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of progressive non-resectable hepatoma].
    Tanikawa K; Tanaka M
    Nihon Naika Gakkai Zasshi; 1994 Sep; 83(9):1562-5. PubMed ID: 7798750
    [No Abstract]   [Full Text] [Related]  

  • 15. [Liver resection after downstaging with systemic chemotherapy in a case of a multicentric hepatocellular carcinoma with virus B cirrhosis].
    Ionescu M; Dumitraşcu T; Stroescu C
    Chirurgia (Bucur); 2007; 102(3):337-43. PubMed ID: 17687865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and implication of multidrug resistance associated -protein gene in primary hepatocellular carcinoma].
    Wang BL; Chen XP; Zhai SP
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):609-11. PubMed ID: 14572339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of chemotherapy in the treatment of malignant liver tumors in childhood].
    Köster B; Bode U
    Klin Padiatr; 1984; 196(5):253-8. PubMed ID: 6092773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma.
    Chen LT; Liu TW; Chao Y; Shiah HS; Chang JY; Juang SH; Chen SC; Chuang TR; Chin YH; Whang-Peng J
    Aliment Pharmacol Ther; 2005 Aug; 22(3):217-26. PubMed ID: 16091059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intermittent intra-arterial chemotherapy using subcutaneously implanted reservoir for hepatocellular carcinoma and liver metastasis of colorectal carcinoma].
    Nakazaki H; Kuramoto S; Watanabe M; Maeda T; Hanawa S; Hasebe Y; Suzuki Y; Yanagita K; Yoshio T
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1501-3. PubMed ID: 1326917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
    Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.